Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
about
Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.Post-epilepsy stroke: A review.Health-related behaviors and comorbidities in people with epilepsy: Changes in the past decade.Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.Network-based approach to prediction and population-based validation of in silico drug repurposing.
P2860
Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Cardiovascular risk factors in ...... carbamazepine or lamotrigine.
@en
Cardiovascular risk factors in ...... carbamazepine or lamotrigine.
@nl
type
label
Cardiovascular risk factors in ...... carbamazepine or lamotrigine.
@en
Cardiovascular risk factors in ...... carbamazepine or lamotrigine.
@nl
prefLabel
Cardiovascular risk factors in ...... carbamazepine or lamotrigine.
@en
Cardiovascular risk factors in ...... carbamazepine or lamotrigine.
@nl
P2093
P1476
Cardiovascular risk factors in ...... carbamazepine or lamotrigine.
@en
P2093
M Rauchenzauner
S Svalheim
P356
10.1111/J.1600-0404.2010.01372.X
P577
2010-01-01T00:00:00Z